TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.

Kevin J Harrington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.